|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
1685846548 |
| 003 |
DE-627 |
| 005 |
20231030141133.0 |
| 007 |
tu |
| 008 |
191217s2020 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2019056340
|
| 020 |
|
|
|a 9780190080457
|c hardback
|9 978-0-19-008045-7
|
| 024 |
3 |
|
|a 9780190080457
|
| 035 |
|
|
|a (DE-627)1685846548
|
| 035 |
|
|
|a (DE-599)KXP1685846548
|
| 035 |
|
|
|a (OCoLC)1190873209
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a RM301.25
|
| 082 |
0 |
|
|a 615.1/9
|q LOC
|
| 084 |
|
|
|a XB 5090
|q DE-24/20sred
|2 rvk
|0 (DE-625)rvk/152475:12999
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 084 |
|
|
|a 44.01
|2 bkl
|
| 100 |
1 |
|
|a Cordes, Eugene H.
|e verfasserin
|0 (DE-627)1230622039
|0 (DE-576)160622034
|4 aut
|
| 245 |
1 |
0 |
|a Hallelujah moments
|b tales of drug discovery
|c Eugene H. Cordes
|
| 250 |
|
|
|a Second edition
|
| 264 |
|
1 |
|a New York, NY
|b Oxford University Press
|c 2020
|
| 300 |
|
|
|a xvi, 310 Seiten, 2 zweiseitig bedruckte ungezählte Blätter
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Enthält Index
|
| 520 |
|
|
|a "This work provides eleven stories of drug discovery and features the scientists who made them. The outcome of the discovery work has provided novel therapies in cancer, cardiovascular medicine, antibacterial and antiviral infectious diseases, parasitic diseases, metabolic diseases, and weight control. Each story begins with the basic biomedical science that revealed the pathway to effective drug therapy and continues with the step-by-step process that leads from insight to a product in clinical practice meeting a defined medical need. The tales feature creative problem solving by clever and dedicated scientists as they overcame roadblocks to success., hallelujah moments. Each drug discovery story reflects the interface between basic science, medicine, and drug discovery. Embedded in these tales are the societal and medical environments in which drug discovery takes place, the discovery of agents to treat HIV/AIDS, for example. Finally, a series of appendices provides basic chemical background for non-scientists"--
|
| 650 |
|
0 |
|a Drug development
|
| 650 |
|
0 |
|a Developmental pharmacology
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4003120-2
|0 (DE-627)106390600
|0 (DE-576)208850341
|a Arzneimittelforschung
|2 gnd
|
| 689 |
0 |
1 |
|D b
|0 (DE-588)5284383-X
|0 (DE-627)244717907
|0 (DE-576)196978270
|a Merck & Co.
|2 gnd
|
| 689 |
0 |
2 |
|A z
|2 gnd
|a Geschichte 1970-2000
|
| 689 |
0 |
|
|5 DE-101
|
| 776 |
1 |
|
|z 9780190080471
|c epub
|
| 776 |
1 |
|
|z 9780190080464
|c updf
|
| 776 |
1 |
|
|z 9780190080488
|c Online
|
| 856 |
4 |
2 |
|u https://www.gbv.de/dms/bowker/toc/9780190080457.pdf
|v 2020-10-19
|x Aggregator
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_754
|
| 912 |
|
|
|a ISIL_DE-B1532
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a ISIL_DE-24
|
| 912 |
|
|
|a GBV_ILN_2011
|
| 912 |
|
|
|a ISIL_DE-16
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a ISIL_DE-31
|
| 936 |
r |
v |
|a XB 5090
|b Pharmakologie, Toxikologie
|k Medizin
|k Geschichte der Medizin
|k Spezielle Geschichte der Medizin, Geschichte einzelner medizin. Disziplinen
|k Pharmakologie, Toxikologie
|k B. Sachschlüssel
|k Unterteilung nach medizinischen Disziplinen
|k Pharmakologie, Toxikologie
|0 (DE-627)1276775113
|0 (DE-625)rvk/152475:12999
|0 (DE-576)206775113
|
| 936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|0 (DE-627)106423304
|
| 936 |
b |
k |
|a 44.01
|j Geschichte der Medizin
|0 (DE-627)106409638
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615.1/9
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 4366844532
|c 00
|f MAG
|d 2971-8409
|e --%%--
|j --%%--
|y k
|z 30-10-23
|
| 980 |
|
|
|2 754
|1 01
|x 3754
|b 3816655327
|c 00
|f --%%--
|d 2021/31
|e u
|j --%%--
|y z
|z 03-12-20
|
| 980 |
|
|
|2 2008
|1 01
|x DE-24
|b 3684154202
|c 00
|f --%%--
|d 70/4997
|e --%%--
|j --%%--
|c 01
|f Freihand
|d XB 5090 70/4997
|e --%%--
|j --%%--
|y l01
|z 08-06-20
|
| 980 |
|
|
|2 2011
|1 01
|x DE-16
|b 3929617455
|c 00
|f --%%--
|d UBN/XB 5090 C794(2)
|e --%%--
|j --%%--
|y l01
|z 19-05-21
|
| 980 |
|
|
|2 2018
|1 01
|x DE-31
|b 3929058642
|c 00
|f --%%--
|d --%%--
|e --%%--
|j l
|y l01
|z 17-05-21
|
| 983 |
|
|
|2 754
|1 01
|x 3754
|8 00
|a 615 C794
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$103665481
|
| 984 |
|
|
|2 754
|1 01
|x 3754
|a 11064650
|
| 984 |
|
|
|2 2011
|1 01
|x DE-16
|a 106444711
|
| 985 |
|
|
|2 754
|1 01
|x 3754
|a 2021/31
|
| 998 |
|
|
|2 754
|1 01
|x 3754
|0 2021-02
|
